Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Parathyroid hormone-anti-RANKL antibody fusion compounds

Parathyroid hormone-anti-RANKL antibody fusion compounds

US Patent 11492386 · Granted Nov 8, 2022

Estimated economic value: $1,119,265,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and methods targeting interleukin-342024
Antibodies to IL-342023
BTLA agonist antibodies and uses thereof2022
Growth differentiation factor 15 agonist compounds and methods of using the same2021
GIP/GLP1 co-agonist compounds2021
Anti-RANKL antibodies and uses thereof2021
BTLA agonist antibodies and uses thereof2020
Anti-Dkk-1-anti-RANKL bispecific antibody compounds2020
Silicon-on-insulator structure having bipolar stress, and manufacturing method t2019
Anti-CXCR4 antibodies2011
Anti-CXCR4 antibodies2011